|
|
Blondon M, Jimenez D, Robert-Ebadi H, Del Toro J, Lopez-Jimenez L, Falga C, Skride A, Font L, Vazquez FJ, Bounameaux H, Monreal M; RIETE investigators.. Comparative clinical prognosis of massive and non-massive pulmonary embolism: a registry-based cohort study. J Thromb Haemost. 2020 Oct 29. doi: 10.1111/jth.15146. [Epub ahead of print]
|
|
|
Letter to the Editor
Autores: Bernabeu-Wittel M, Gómez-Huelgas R, Nieto-Martín MD; SEMI-COVID-19 Network.
J Am Geriatr Soc. 2020 Nov 12. doi: 10.1111/jgs.16943. Online ahead of print.
|
Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2 diabetes mellitus admitted for COVID-19.
|
(1) Background: Different clinical presentations in COVID-19 are described to date, from mild to severe cases. This study aims to identify different clinical phenotypes in COVID-19 pneumonia using cluster analysis and to assess the prognostic impact among identified clusters in such patients. (2) Methods: Cluster analysis including 11 phenotypic variables was performed in a large cohort of 12,066 COVID-19 patients, collected and followed-up from 1 March to 31 July 2020, from the nationwide Spanish Society of Internal Medicine (SEMI)-COVID-19 Registry.
|
Background: Advanced age is a well-known risk factor for poor prognosis in COVID-19. However, few studies have specifically focused on very old inpatients with COVID-19. This study aims to describe the clinical characteristics of very old inpatients with COVID-19 and identify risk factors for in-hospital mortality at admission.
|
Background: Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the association between blood glucose (BG) levels and in-hospital mortality in non-critically patients hospitalized with COVID-19.
|
It is unclear to which extent the higher mortality associated with hypertension in the coronavirus disease (COVID-19) is due to its increased prevalence among older patients or to specific mechanisms. Cross-sectional, observational, retrospective multicenter study, analyzing 12226 patients who required hospital admission in 150 Spanish centers included in the nationwide SEMI-COVID-19 Network. We compared the clinical characteristics of survivors versus non-survivors. The mean age of the study population was 67.5 ± 16.1 years, 42.6% were women. Overall, 2630 (21.5%) subjects died.
|
Autores:
Javier Plaza Zamora, Guillermo Estrada Riolobos, Jesús C. Gómez Martínez, Vicente J. Baixauli Fernández, Ana Molinero Crespo, Eduardo Satué de Velasco, Luis Salar Ibáñez, Neus Caelles Franch (SEFAC)
Vicente Martín Sánchez, Vicente Olmo Quintana (SEMERGEN)
Juan González Armengol (SEMES)
Ma Isabel Gutiérrez Pérez (SEMFYC) Lorenzo Armenteros del Olmo (SEMG) Ricardo Gómez Huelgas (SEMI)
Concepción Prados Sánchez y Alberto Mangas Moro (SEPAR)
|
